Wang, X.; Hu, T.; Jiang, Y.; He, Y.; Li, P.; Peng, W.; Wang, Y.; Su, W.
Jingzhi Guanxin Oral Liquids Attenuate Atherosclerotic Coronary Heart Disease via Modulating Lipid Metabolism and PPAR-Related Targets. Pharmaceuticals 2024, 17, 784.
https://doi.org/10.3390/ph17060784
AMA Style
Wang X, Hu T, Jiang Y, He Y, Li P, Peng W, Wang Y, Su W.
Jingzhi Guanxin Oral Liquids Attenuate Atherosclerotic Coronary Heart Disease via Modulating Lipid Metabolism and PPAR-Related Targets. Pharmaceuticals. 2024; 17(6):784.
https://doi.org/10.3390/ph17060784
Chicago/Turabian Style
Wang, Xinning, Tao Hu, Yuliang Jiang, Yan He, Peibo Li, Wei Peng, Yonggang Wang, and Weiwei Su.
2024. "Jingzhi Guanxin Oral Liquids Attenuate Atherosclerotic Coronary Heart Disease via Modulating Lipid Metabolism and PPAR-Related Targets" Pharmaceuticals 17, no. 6: 784.
https://doi.org/10.3390/ph17060784
APA Style
Wang, X., Hu, T., Jiang, Y., He, Y., Li, P., Peng, W., Wang, Y., & Su, W.
(2024). Jingzhi Guanxin Oral Liquids Attenuate Atherosclerotic Coronary Heart Disease via Modulating Lipid Metabolism and PPAR-Related Targets. Pharmaceuticals, 17(6), 784.
https://doi.org/10.3390/ph17060784